Gene · 5927
Papers1,684
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,684
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic control of dental stem cells: progress and prospects in multidirectional differentiation. | Epigenetics Chromatin | 2024 | 39623487 | PubTator, text mining | PubMed |
| ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer. | Cell Rep | 2024 | 39570746 | PubTator, text mining | PubMed |
| Transcriptome Profiling Associated with CARD11 Overexpression in Colorectal Cancer Implicates a Potential Role for Tumor Immune Microenvironment and Cancer Pathways Modulation via NF-κB. | Int J Mol Sci | 2024 | 39408697 | PubTator, text mining | PubMed |
| Prognostic importance of NUP98-rearrangements in acute myeloid leukemia: A systematic review and meta-analysis. | Caspian J Intern Med | 2024 | 39359452 | PubTator, text mining | PubMed |
| miR-96-5p expression is sufficient to induce and maintain the senescent cell fate in the absence of stress. | Proc Natl Acad Sci U S A | 2024 | 39325426 | PubTator, text mining | PubMed |
| Inflammatory factor TNFα-induced circDMD mediates R-loop formation to promote tumorigenesis. | Int J Biol Macromol | 2024 | 39288863 | PubTator, text mining | PubMed |
| Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer. | Int J Med Sci | 2024 | 39239542 | PubTator, text mining | PubMed |
| Genomic analysis reveals molecular characterization of CD30+ and CD30- extranodal natural killer/T-cell lymphomas (ENKTLs). | Hum Pathol | 2024 | 39187207 | PubTator, text mining | PubMed |
| Expression and clinical significance of KDM5A, KDM5B, and FOXO1 in endometrial cancer. | Pol J Pathol | 2024 | 39166517 | PubTator, text mining | PubMed |
| Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. | Genes Dev | 2024 | 38914477 | PubTator, text mining | PubMed |
| Integrative ceRNA network analysis identifies unique and shared molecular signatures in Bipolar Disorder and Schizophrenia. | J Psychiatr Res | 2024 | 38843579 | PubTator, text mining | PubMed |
| KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges. | Mol Cancer | 2024 | 38769556 | PubTator, text mining | PubMed |
| Effect of Low-Level Tragus Stimulation on Cardiac Metabolism in Heart Failure with Preserved Ejection Fraction: A Transcriptomics-Based Analysis. | Int J Mol Sci | 2024 | 38673896 | PubTator, text mining | PubMed |
| Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells [Retraction]. | Onco Targets Ther | 2024 | 38650606 | PubTator, text mining | PubMed |
| Histone Lysine Demethylase KDM5 Inhibitor CPI-455 Induces Astrocytogenesis in Neural Stem Cells. | ACS Chem Neurosci | 2024 | 38501572 | PubTator, text mining | PubMed |
| Discovering ferroptosis-associated tumor antigens and ferroptosis subtypes in pancreatic adenocarcinoma to facilitate mRNA vaccine development. | Heliyon | 2024 | 38463885 | PubTator, text mining | PubMed |
| The KDM5 inhibitor PBIT reduces proliferation of castration-resistant prostate cancer cells via cell cycle arrest and the induction of senescence. | Exp Cell Res | 2024 | 38462208 | PubTator, text mining | PubMed |
| Identifying ligands for the PHD1 finger of KDM5A through high-throughput screening. | RSC Chem Biol | 2024 | 38456036 | PubTator, text mining | PubMed |
| Mechanism of KDM5A-mediated H3K4me3 modification in the osteogenic differentiation of mesenchymal stem cells in steroid-induced osteonecrosis of the femoral head. | Int J Rheum Dis | 2024 | 38443978 | PubTator, text mining | PubMed |
| Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies. | NPJ Precis Oncol | 2024 | 38429350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5927/papers?page=5